英: agenesis of pancreatic body and tail, agenesia of pancreatic body and tail
関: 膵体尾部、膵臓

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 膵外分泌癌の治療における外科手術の概要overview of surgery in the treatment of exocrine pancreatic cancer and prognosis [show details]
… Whipple procedure would not). This typically occurs when a tumor of the pancreatic head extends into the body or tail of the pancreas. Total pancreatectomy also plays a role in the treatment of some main-duct …
2. 膵管内乳頭粘液性腫瘍（IPMN）：評価およびマネージメントintraductal papillary mucinous neoplasm of the pancreas ipmn evaluation and management [show details]
… if a patient has a MD-IPMN in the head of the pancreas with malignant features, and a BD-IPMN in the tail of the pancreas that is 12 mm and lacks malignant features,… given the "field defect" nature of IPMN, a negative surgical margin does not preclude the presence of neoplasia in the remnant pancreas .…
3. 膵体および膵体尾部病変の外科的切除surgical resection of lesions of the body and tail of the pancreas [show details]
… pancreatectomy, which removes the body and tail of the pancreas, accounts for approximately 25 percent of all pancreatic resections. Distal pancreatectomy was first performed by Billroth in 1884. Less extensive …
4. 嚢胞性線維症：消化器疾患の概要cystic fibrosis overview of gastrointestinal disease [show details]
… Insufficient pancreatic enzyme activity – Approximately 90 percent of patients with DIOS have pancreatic insufficiency . Some but not all studies suggest that inadequate doses of pancreatic enzymes might …
5. 膵嚢胞の分類classification of pancreatic cysts [show details]
… IPMNs, MCNs demonstrate ovarian-like stroma , typically arise in the pancreatic tail or body , and do not communicate with the pancreatic duct. Due to the risk of malignancy developing, resection is recommended …